The Laboratory of
HIV Immunopathogenesis
and Emerging Pathogens

Our mission is to understand the pathogenic mechanisms underlying complications impacting people with HIV particularly among those receiving virally suppressive antiretroviral therapy across a spectrum of ages. Using state of the art immunological, virological and molecular epigenetic modalities, we aim to exploit this knowledge in developing novel approaches and effective therapeutics to improving quality of life outcomes and ultimately a cure for HIV. Our team is actively engaged in pre-clinical and clinical studies to ultimately achieve these goals.